Semax

Also known as: MEHFPGP

Limited evidence
ClassSynthetic ACTH(4-10) analog
Research statusApproved in Russia; unapproved elsewhere
Independent tests0
Studies indexed1

Overview

Semax is a synthetic fragment analog of adrenocorticotropic hormone with proposed BDNF-mediated neuroprotective effects. It is used clinically in Russia; as with Selank, Western replication and regulatory review are absent.

Research & Studies

Studies library
  • Semax in acute ischemic stroke: multicenter clinical experience

    Zhurnal Nevrologii (translated summary) · Clinical series · Jan 1, 2005

    Russian clinical evidence base for Semax; not independently replicated in Western trials.

Latest Coverage

Community Discussions

Forum

The Peptide Institute Weekly

Research. Testing. Regulation. No hype.

One email a week: new study summaries, the latest independent lab results, ranking movements, and regulatory developments that matter.

  • New research, summarized in plain English
  • Independent lab results as they publish
  • Score and ranking movements